Patient Reported Outcomes of Antithrombotic Drug Management for Colonoscopy

Go Back to All Clinical Trials

Patient Reported Outcomes of Antithrombotic Drug Management for Colonoscopy

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

Conditions:
Currently On Antithrombotic Medication
Age: Between 45 Year(s) - 75 Year(s)
Gender: Male or Female

Other Inclusion Criteria:
1. Current NYU Langone patient
2. On antithrombotic medication (antiplatelet and anticoagulant drugs) either at the time of interview or in the year prior to the interview. These inclusive medications include: warfarin, apixaban, dabigatran, edoxaban, and rivaroxaban, clopidogrel, prasugrel, and ticagrelor.
3. Currently scheduled for a colonoscopy or recently completed a colonoscopy (within the last year)
4. Ages 45 to 75

You may not be eligible for this study if the following are true:

1. Not currently an NYU Langone patient
2. Not on antithrombotic medication (antiplatelet and anticoagulant drugs) either at the time of interview or in the year prior to the interview.
3. Not currently scheduled for a colonoscopy or recently completed a colonoscopy (in the last year)
4. Under the age of 45 or above the age of 75

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies